Genetic Dissection of Antibiotic Adjuvant Activity

Area of Science:

• Microbiology and Molecular Genetics
• Antimicrobial Resistance Research
• Drug Discovery and Development

Background:

• Antibiotic resistance is a major global health threat, necessitating novel therapeutic strategies.
• Small molecule adjuvants enhance existing antibiotic efficacy by targeting resistance mechanisms.
• Understanding adjuvant mechanisms of action is crucial for their development as drugs.

Purpose of the Study:

• To present a complementary genetic strategy for identifying antibiotic adjuvant mechanisms of action.
• To characterize the targets of avibactam and aryl 2-aminoimidazole AI-1 in Acinetobacter baumannii.
• To identify key genes involved in antibiotic resistance in Acinetobacter baumannii.

Main Methods:

• A genetic approach was employed to identify mutations conferring 'adjuvant blindness' in Acinetobacter baumannii.
• Two adjuvants, avibactam (a beta-lactamase inhibitor) and AI-1 (an outer membrane permeability enhancer), were tested.
• Mutations affecting disulfide bond formation and lipooligosaccharide (LOS) synthesis/acylation were analyzed.

Main Results:

• Avibactam's potentiation of ceftazidime and meropenem was linked to specific beta-lactamases (GES-14, OXA-23) and potentially disulfide bond formation.
• AI-1's potentiation of vancomycin and clarithromycin was dependent on lipooligosaccharide (LOS) synthesis and its acylation, highlighting outer membrane permeability.
• The study identified key resistance genes for multiple antibiotics in Acinetobacter baumannii and validated findings in Acinetobacter baylyi.

Conclusions:

• A novel genetic strategy effectively elucidates antibiotic adjuvant mechanisms of action.
• Adjuvant activity is linked to specific enzymatic targets (beta-lactamases) and outer membrane properties (LOS synthesis and acylation).
• This research provides a foundation for analyzing adjuvant action and combating antibiotic resistance.